Contact us: info@cirsa.com.au

Cardiac Imaging Research SA

Our Core Lab in South Australia

 

The Lab

 

 

Founded in 2008 by Professor Joseph Selvanayagam and based in Adelaide, Australia, our Cardiac Imaging Core Lab is an academic research organisation (ARO). We provide comprehensive cardiac imaging services for multicentre national and international clinical trials sponsored by the pharmaceutical, biotechnology and medical device industries.

 

Our Core Lab provides specialised academic research services across both Cardiovascular Magnetic Resonance (CMR) and Echocardiography (ECHO). We support investigator-initiated research and collaborate with academic research organisations, contract research organisations (CROs) and industry partners to develop, implement and successfully deliver high-quality cardiac imaging components of clinical trials.

 

Our Core Lab provides end-to-end cardiac imaging support, including imaging protocol development, imaging manuals and study documentation, site feasibility and selection, site engagement and qualification, image quality assurance, imaging adjudication and analysis, data management and reporting.

 

With extensive experience supporting multicentre cardiac imaging studies, we bring together specialist imaging expertise, academic excellence and robust quality processes to support consistent, reliable and high-quality imaging outcomes across clinical trial sites.

Joseph Selvanayagam

 

 

 

 

We are the CMR/ ECHO Core Lab for the following research studies:

 

1) CMR GUIDE: Cardiovascular Magnetic Resonance GUIDEd management of mild-moderate left ventricular systolic Heart Failure

2) PROTECT-MI: Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction

3) MiSaver: Safety and Efficacy Study of Cells derived from Umbilical Cord Blood

4) AT-02: Targeting Amyloid Deposits in Systemic Amyloidosis

5) PROTECTION AMI : Phase 2b study in STEMI using novel anti-apoptotic agent.

Click here for publication 

6) The NACIAM Trial : Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size.

Click here for publication

 

 

 

 

 

Looking for more information?

CONTACT US